Biologe/ Pharmazeut/Biochemiker als in vivo Wissenschaftler/Postdoc für die onkologische Wirkstoffentwicklung

 NanoCapture  München
The NanoCapture project is focused on developing selective delivery of nanomedicines to treat cancers. We are based in the Department of Pharmacy at Ludwig-Maximilians-Universität Munich. Recently, the NanoCapture team won the prestigious GO-Bio grant from German Federal Government - BMBF, to perform preclinical studies for our innovative approach in order to attract the investment and spin-off into a biotech company.
To strengthen our interdisciplinary team, we are looking for a postdoc specialist in tumor biology. The ideal candidate should have a strong background in tumor biology and pathology as well as in in vivo tumor mouse models. In addition, the candidate should have extensive knowledge of the tumor microenvironment and vasculature as well as mechanisms of chemotherapy. A strong entrepreneurial drive is highly desirable. She/He will be responsible for establishing and performing preclinical studies to characterize in detail the mode of action underlying the NanoCapture concept and to provide a proof of increased efficacy of our approach compared to conventional treatments.

Activities and responsibilities

Main responsibilities:
 
  • Establishing and performing in vivo tumor mouse model studies
  • Designing the key studies to understand the NanoCapture concept
  • Investigating changes in the tumor micro-environment and vasculature
  • Data interpretation, manuscript preparation (patent and publications)
  • Presentation and reporting the research outcome internally and externally
  • Involvement in creating scientific and business strategies  

Qualification profile

Skills and Requirements:
You should have genuine interest in the field of drug development with a strategic and entrepreneurial mind-set. Ideally, you are self-starter and an inventive problem-solver comfortable to work independently and within a team.
  • PhD in an appropriate field
  • Proven record in tumor biology, pathology and in vivo mouse models (FELASA certification preferred)
  • Experience in development and preclinical evaluation of chemo- and nanotherapeutics
  • In-depth knowledge of state-of-the-art concepts of cancer therapy (chemo-, radio- and immunotherapy)
  • Professional experience in pharma/biotech industry is of advantage
  • High proficiency in English and German language, excellent presentation and communication skills

Benefits

We are offering:
  • Interesting and multifaceted job responsibilities
  • Dynamic, interdisciplinary team with flat hierarchy – possibility to directly contribute to the project strategy and future
  • Possibility to be one of company’s founder
  • Biotech start-up environment and opportunities for further professional development (specialized courses and trainings)
  • Contract according to TV-L up to E14, flexible working hours
  • Work place at the High-Tech Campus Großhadern in Munich, easily reachable by public transport and car
You will join a truly interdisciplinary and highly-motivated team working on a novel cancer therapy that can make a real-world impact. The position (TV-L, up to E14) is available immediately, initially for three years (Phase 1, GO-Bio). After  Phase 1 and successful spin-off we will transition together into newly founded company.

Send application to

Please send your cover letter, CV and references per Email to:
Dr. Petar Marinković
petar.marinkovic@cup.lmu.de
LMU München, Department Pharmazie
+49(0)89/2180-71034
www.nanocapture.de
http://thornseshold.cup.uni-muenchen.de/research/nanocapture/

While applying for the job please refer to jobvector

About NanoCapture

The NanoCapture project is focused on developing the selective delivery of nanomedicines to treat cancers. We are based in the Department of Pharmacy, Ludwig-Maximilians-Universität at the High-Tech Campus Großhadern/Munich. Recently, the NanoCapture team won the prestigious GO-Bio grant from German Federal Government - BMBF, to perform preclinical studies for our innovative approach and to...
More about NanoCapture